Inhalation Sciences: IRS order with large generic pharma company
Research Note
2022-10-28
10:45
Redeye is positive for ISAB’s continued high sales activity. Today, the company announced it has signed a new IRS order worth SEK1.2m with a large generic pharma company. We look forward to the Q3’22 report at the end of November and reiterate our Base Case of SEK23.
GM
Gustaf Meyer
Disclosures and disclaimers